Javara

Javara raises undisclosed Series C funding to expand healthcare partnerships and diversify clinical research

28th May, 2025

Chris Davis

Writer

Javara raises undisclosed Series C funding to expand healthcare partnerships and diversify clinical research

What does Javara do?

Javara is an integrated research organization (IRO) that collaborates with healthcare organizations to deliver clinical trial access at the point of care. Its centralized resources, standardized operations, and integrated research staff help accelerate study startups and improve clinical trial outcomes.

How much did they raise?

The company raised an undisclosed amount in a Series C funding round, with details on lead and participant investors not disclosed.

What are their plans for the money?

The new funds will be used to expand existing healthcare partnerships and support the company’s move into new therapeutic specialties such as Oncology, CNS, and Neurology. This expansion is aimed at doubling both patient and physician reach while amplifying its geographic footprint.

What have they achieved so far?

Javara has already made significant progress by providing access to over 5 million patients across 7 states and streamlining clinical trial operations to reduce obstacles in the product approval process.

Key Contacts

Jennifer Byrne
CEO

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom